KX2-361 is an orally administered small molecule that concurrently inhibits Src kinase and tubulin polymerization. This dual-action inhibitor has demonstrated efficacy in preclinical glioblastoma research, significantly extending survival in murine models and showing potent anti-proliferative activity in vitro against cancer cell lines.
Molecular Weight:
405.46
Purity:
99.86% (May vary between batches)
CAS Number:
[897016-26-1]
Formula:
C24H24FN3O2
Target:
Apoptosis,Src,Microtubule Associated
Application Notes:
Solubility: DMSO:8.75 mg/mL (21.58 mM)
* VAT and and shipping costs not included. Errors and price changes excepted